ArticleClinical ophthalmology (Auckland, N.Z.)2017
Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss.
Article in Clinical ophthalmology (Auckland, N.Z.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.
- Pooled it
- Low vision rehabilitation for better quality of life in visually impaired adults.The Cochrane database of systematic reviews · 2020Pooled it
- Review
- Article
- Multidimensional relationships between sensory perception and cognitive aging.Frontiers in aging neuroscience · 2024Article
- The treatment efficacy of radiotherapy for optic nerve sheath meningioma.Eye (London, England) · 2024Article
- Visual function tests for glaucoma practice - What is relevant?Indian journal of ophthalmology · 2022Review
- Toward Improving the Mobility of Patients with Peripheral Visual Field Defects with Novel Digital Spectacles.American journal of ophthalmology · 2020Article
- Expansion of Peripheral Visual Field with Novel Virtual Reality Digital Spectacles.American journal of ophthalmology · 2020Article
- Mobility improvement of patients with peripheral visual field losses using novel see-through digital spectacles.PloS one · 2020Article
- Disparities in Low-Vision Device Use Among Older US Medicare Recipients.JAMA ophthalmology · 2018Article
- Comment on "Clinical effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss".Clinical ophthalmology (Auckland, N.Z.) · 2017Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe aim of this trial is to study the effectiveness of currently available low-vision devices in glaucoma patients with moderate-to-severe vision loss.
designThis is a randomized pilot clinical trial.
participantsSixteen low-vision glaucoma patients participated in this study.
methodsPatients with a best-corrected visual acuity between 20/70 and 20/400 in the better eye and a diagnosis of stable primary or secondary open-angle glaucoma were randomized to a low-vision treatment group or a nonintervention control group. A telephone interview was conducted before and after the 4-week testing period to assess functional vision. Patients placed in the treatment group received a low-vision examination and used various currently available low-vision aids. Patients placed in the control group received a low-vision examination only. Changes in patients' reading ability and overall visual ability were chosen as the primary outcomes. Other visual functioning domains (mobility, visual information processing and visual motor skills) were considered as secondary outcomes.
resultsTen patients in the treatment group showed a significant improvement in reading ability and overall visual ability compared to the control group. The difference in mean score for reading ability was 2.52 logits (2.02;
conclusionCurrently available low-vision devices primarily enhance central vision with limited benefits to functional activities relying on peripheral vision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.